Goldman Sachs’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.8M Buy
1,228,184
+411,962
+50% +$8.66M ﹤0.01% 1594
2025
Q1
$13.4M Sell
816,222
-941,911
-54% -$15.4M ﹤0.01% 2010
2024
Q4
$45.2M Buy
1,758,133
+888,950
+102% +$22.8M 0.01% 1158
2024
Q3
$27.5M Buy
869,183
+192,449
+28% +$6.1M ﹤0.01% 1487
2024
Q2
$23.8M Buy
676,734
+257,835
+62% +$9.05M ﹤0.01% 1475
2024
Q1
$18.4M Buy
418,899
+140,733
+51% +$6.18M ﹤0.01% 1606
2023
Q4
$9.9M Sell
278,166
-141,856
-34% -$5.05M ﹤0.01% 2099
2023
Q3
$11.3M Buy
420,022
+29,943
+8% +$808K ﹤0.01% 1898
2023
Q2
$9.17M Buy
390,079
+198,350
+103% +$4.66M ﹤0.01% 2104
2023
Q1
$2.63M Buy
191,729
+30,898
+19% +$424K ﹤0.01% 3020
2022
Q4
$2.92M Buy
160,831
+49,110
+44% +$892K ﹤0.01% 3014
2022
Q3
$1.67M Buy
111,721
+10,730
+11% +$160K ﹤0.01% 3480
2022
Q2
$1.39M Sell
100,991
-90,996
-47% -$1.26M ﹤0.01% 3719
2022
Q1
$2.15M Buy
191,987
+87,482
+84% +$979K ﹤0.01% 3531
2021
Q4
$2.47M Buy
104,505
+48,621
+87% +$1.15M ﹤0.01% 3342
2021
Q3
$1.42M Buy
55,884
+18,410
+49% +$469K ﹤0.01% 3734
2021
Q2
$786K Buy
37,474
+3,054
+9% +$64.1K ﹤0.01% 4174
2021
Q1
$809K Buy
34,420
+5,036
+17% +$118K ﹤0.01% 4049
2020
Q4
$411K Buy
29,384
+19,060
+185% +$267K ﹤0.01% 3930
2020
Q3
$130K Sell
10,324
-147,931
-93% -$1.86M ﹤0.01% 4172
2020
Q2
$2.25M Buy
158,255
+131,892
+500% +$1.87M ﹤0.01% 2781
2020
Q1
$109K Buy
26,363
+6,506
+33% +$26.9K ﹤0.01% 4148
2019
Q4
$149K Sell
19,857
-42,841
-68% -$321K ﹤0.01% 4063
2019
Q3
$564K Sell
62,698
-55,709
-47% -$501K ﹤0.01% 3541
2019
Q2
$1.18M Buy
+118,407
New +$1.18M ﹤0.01% 3094